NTRB Stock Analysis: Buy, Sell, or Hold?
NTRB - Nutriband Inc. Common Stock
$3.11
0.21 (7.24%)
▲
5d:
-8.26%
30d:
-11.9%
90d:
-15.72%
HOLD
LOW Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: May 29, 2026
0d
Get Alerted When NTRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NTRB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NTRB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.49
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$3.41
8.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NTRB is currently trading at $3.11, which is considered oversold relative to its 30-day fair value range of $3.27 to $3.62. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.1) compared to its historical average (2.7). Remarkably, the market is currently pricing in an annual earnings decline of 8.0% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NTRB is in a strong downtrend. The price is currently testing key support at $3.21. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 7.2% recently.
Market Sentiment: NTRB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.00 (+382.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NTRB is in a strong downtrend. The price is currently testing key support at $3.21. A bounce from this level would confirm strength, while a break below could signal further downside. The stock is showing strong short-term momentum, up 7.2% recently.
Market Sentiment: NTRB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.00 (+382.3%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.27 -
$3.62
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+7.2%)
- BULLISH: Trading 382.3% below Wall St target ($15.00)
- CAUTION: Recommendation downgraded due to -8.3% 5-day decline
Trading Range Analysis
30-Day Trading Range
$3.27 -
$3.62
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.21
Resistance Level
$3.69
Current Trend
Strong Downtrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.14
Wall Street Target
$15.00
(+382.3%)
Revenue Growth (YoY)
-35.1%
Valuation Discount vs History
-8.0% cheaper
PE vs Historical
2.1 vs 2.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.0%
(market-implied from PE analysis)
1-Year Target
$2.86
(-8%)
2-Year Target
$2.63
(-15%)
3-Year Target
$2.42
(-22%)
3-Yr Target (if PE normalizes)
(PE: 2→3)
$3.05
(-2%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.1 to 2.7
Stabilization Target:
$3.92
(+25.9%)
PE Expansion Potential:
+25.9%
Share & Embed Analysis
Last updated: June 23, 2026 1:41 AM ET
Data refreshes hourly during market hours. Next update: 2:41 AM
Data refreshes hourly during market hours. Next update: 2:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 59 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$436 | 55 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 69 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 58 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 52 HOLD |
